Atlas Trials

Study of ONO-4538 in Unresectable Advanced or Recurrent Gastric Cancer

Clinical trial NCT02267343 · COMPLETED

Trial details

NCT number
NCT02267343
Sponsor
Ono Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2014-10-01
Primary completion
2016-08-01
Enrollment
493

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.